Pharmabiz

Indian pharma cos to benefit as drugs worth $236 billion expected to go off-patent in next five years

Nandita Vijayasimha, Bengaluru Tuesday, September 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz

Bombay HC strikes down blanket stop-production orders issued against two pharma cos by Maharashtra FDA

Peethaambaran Kunnathoor, Chennai Tuesday, September 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz

US 100% tariff on branded pharma products unlikely to have any impact on Indian generic drug exports: Industry experts

Shardul Nautiyal, Mumbai Tuesday, September 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz

PCI refuses permission to 89 institutions in Maharashtra for 1st year admission for AY 2025-26

Our Bureau, New Delhi Tuesday, September 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz

MDC seeks clarity on application for exemption of nafithromycin from DPCO

MDC seeks clarity on application for exemption of nafithromycin from DPCO: Gireesh Babu, New Delhi Tuesday, September 30, 2025, 08:00 Hrs [IST] The Multidisciplinary Committee of ...